Delivery Order SPE2DB20D1100-SPE2DB25FD7S1
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $2,174.90 to supply 100 tablets of Nucynta 50 mg, a prescription opioid pain medication. This non-set-aside, competitively awarded contract was executed on August 22, 2025, with an ultimate completion date of August 25, 2025, and reflects a firm fixed-price arrangement. The order is being fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,013.96 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 150 mg, an extended-release opioid pain medication. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by August 25, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,225.04 to AmerisourceBergen Drug Corp for 100 tablets of Nucynta 50 mg, a prescription opioid pain medication. The contract, which is a child order under a larger indefinite delivery vehicle, was competitively awarded without set-aside provisions and carries a firm fixed price structure. The delivery order was awarded on May 30, 2025, with an ultimate completion date of June 2, 2025. Performance will occur at...
- The Defense Logistics Agency awarded a delivery order valued at $3,761.86 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 200 mg, a prescription opioid pain medication. The contract, executed on July 28, 2025, with an ultimate completion date of July 29, 2025, employs firm fixed-price pricing with no set-aside designation, indicating competitive award status. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $2,928.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 200 mg, a prescription opioid pain management medication. The contract, awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 200 mg, a prescription opioid pain management medication, with a contract ceiling value of $2,411.52. This is a firm fixed-price delivery order issued on August 6, 2025, with an ultimate completion date of August 7, 2025, with no set-aside designation. The place of performance is the company's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,531.10 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 150 mg, a prescription opioid pain management medication. The award, made on May 20, 2025, with completion targeted for May 21, 2025, utilized firm fixed price contracting with no set-aside designation, indicating competitive award procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,670.65 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 100 mg, an extended-release opioid pain medication. This non-set-aside, firm fixed-price delivery order was awarded on August 29, 2025, with an ultimate completion date of September 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction...
- The Defense Logistics Agency awarded a $3,580.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Nucynta 75 mg, a prescription opioid pain management medication. The contract, awarded on September 18, 2025, with completion targeted for September 19, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This award was not designated as a set-aside and was competitively...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,810.39 for 60-count tablets of Nucynta ER 50 mg, an opioid pain management medication. Issued on September 4, 2025, with an ultimate completion date of September 5, 2025, this firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract will be performed at the vendor's corporate...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD7S1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,979.28 to AmerisourceBergen Drug Corp for 100 tablets of Nucynta 100 mg, a prescription opioid pain medication. This non-set-aside, competitively awarded delivery order reflects firm fixed pricing and was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support Department of Defense and veteran healthcare systems globally. The company's extensive contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains through open competition, positioning it as a key vendor for military healthcare programs and related federal medical supply initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 7/31/25 |